Effect of Lactobacillus supplementation on seizure control, gut microbiota, and blood neurotransmitters in dogs with idiopathic epilepsy
Rattachement africain : es. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Idiopathic epilepsy is one of the most common neurological diseases in dogs; however, epileptogenesis and the mechanisms underlying drug resistance remain poorly understood. This study aimed to evaluate the effects of three months of supplementation with canine-derived Lactobacillaceae strains on seizure frequency in dogs with drug-sensitive epilepsy (DSE) and drug-refractory epilepsy (DRE). Additionally, gut microbiota profiles and plasma levels of GABA, L-glutamate, and serotonin were analysed and compared to those of healthy control dogs. The probiotic supplementation was associated with a reduction in both the number of seizures and seizure days in epileptic dogs. An increase in the relative abundance of gut Lactobacillus and plasma GABA levels did not accompany clinical improvement. However, it was associated with a significant decrease in the GABA/L-Glutamate ratio in dogs with DSE but not in those with DRE. At baseline, heterogeneity of the fecal microbial community (β-diversity) was higher in epileptic compared to controls. Following probiotic supplementation, the differences in β-diversity between control and DSE dogs were no longer observed. The probiotic had no notable effect on the control group but was associated with a significant reduction in β-diversity in dogs with DRE. While the relative abundance of Lactobacillus remained unchanged after probiotic administration, some changes in gut microbiota were observed in epileptic dogs. Numerous associations were identified between seizure frequency and specific bacterial taxa with potential protective effects (e.g.,Prevotella_9, Ligilactobacillus) or risk effects (e.g.,Parasutterella, Helicobacter). These findings suggest that long-term use of Lactobacillus may serve as a promising adjuvant strategy for seizure control.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Effect of Lactobacillus supplementation on seizure control, gut microbiota, and blood neurotransmitters in dogs with idiopathic epilepsy
- Date Crossref
- 01/11/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Universidad de Zaragoza Spain pays non établi dans la noticeUniversité ou école supérieure
-
Hospital Universitario Miguel Servet pays non établi dans la noticeÉtablissement de santé
-
Instituto Universitario de Investigación Mixto Agroalimentario de Aragón (IA2) UNIZAR-CITA Spain pays non établi dans la noticeStructure de recherche
Spain — Universidad de Zaragoza, Hospital Universitario Miguel Servet et Spain — Instituto Universitario de Investigación Mixto Agroalimentario de Aragón (IA2) UNIZAR-CITA.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.